Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hickman

Showing results (461-470 of 519) with videos related to

Pageof 52
Sort By:
Journal of Viral Hepatitis|September 1, 2025
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review DataGetahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, et al.
BMC Public Health|October 23, 2023
Understanding adherence to self-isolation in the first phase of the COVID-19 pandemic in England: a cross-sectional mixed-methods studyCharlotte Robin, Rosy Reynolds, Helen Lambert, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
Wellcome Open Research|August 8, 2022
Tackling Root Causes Upstream of Unhealthy Urban Development (TRUUD): Protocol of a five-year prevention research consortiumDaniel Black, Sarah Ayres, Krista Bondy, et al.
Addiction (Abingdon, England)|July 24, 2018
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugsJason Grebely, Sarah Larney, Amy Peacock, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Global Health|November 16, 2023
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic reviewBehzad Hajarizadeh, Abe Kairouz, Sophie Ottaviano, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
Pageof 52

Showing results (461-470 of 519) with videos related to

Sort By:
Pageof 52
Journal of Viral Hepatitis|September 1, 2025
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review DataGetahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, et al.
BMC Public Health|October 23, 2023
Understanding adherence to self-isolation in the first phase of the COVID-19 pandemic in England: a cross-sectional mixed-methods studyCharlotte Robin, Rosy Reynolds, Helen Lambert, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
Wellcome Open Research|August 8, 2022
Tackling Root Causes Upstream of Unhealthy Urban Development (TRUUD): Protocol of a five-year prevention research consortiumDaniel Black, Sarah Ayres, Krista Bondy, et al.
Addiction (Abingdon, England)|July 24, 2018
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugsJason Grebely, Sarah Larney, Amy Peacock, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
The International Journal on Drug Policy|December 21, 2022
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
The Lancet. Global Health|November 16, 2023
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic reviewBehzad Hajarizadeh, Abe Kairouz, Sophie Ottaviano, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
Pageof 52